The Society of Biomolecular Imaging and Informatics (SBI2) first annual meeting

At the first annual meeting it is the goal of SBI2 to offer the scientific community a high value, low cost meeting with experts in the field from across the globe. In this 3 day meeting we will offer short courses in high-content analysis/high-content screening (HCA/HCS), networking opportunities, and a well rounded scientific program with a focus on recent research.
+ show speakers and program
Session I Assay development and HCS case histories

The development, validation and implementation of novel high content imaging assays combined with evolving strategies for compound and RNAi library screening seek to broaden both the scope of biological processes and/or target classes that can be addressed by HCS, and to improve the quality of information and actives emerging from HCS campaigns. This session will focus on recent innovations in HCS assay development and screening with an emphasis on case histories where the technology has been successfully implemented to interrogate an important biological process and/or to discover novel leads for drug discovery.

Session II Image analysis and informatics

The session will focus on the development and application of novel image processing and data analysis methods for high content analysis (HCA), together with innovative strategies to manage, interpret, and share the large volume of images, data and information produced. Practical examples highlighting the use of experimental design, image correction, image segmentation, data pre-processing, and multivariate statistical methods to analyze and extract quantitative data and information will be given priority, along with cases illustrating the integration of HCA data with other complex data sets including but not limited to gene expression profiling, signaling pathway mapping, DNA sequencing and mutational analysis.

Session III Physiologically-relevant models

High content screening model systems range from 2D in vitro cell lines to whole organisms. Quite often, the direct outcome of drug or chemical screening in cell lines is to evaluate lead candidates in relevant model organisms. This session will focus broadly on different biological systems and their relevance to physiological environments. This could include and is not limited to strategies for screening more complex cell cultures (including primary cells, 3D conditions, co-culturing, cell-substratum interactions), tissues, and intact organisms, as well as strategies for quantitation of phenotypic outcomes.

Session IV Emerging frontiers

We are seeking submissions on new material that is at the cutting edge of biomolecular imaging and informatics. We are looking to excite and inspire the current and next generation of researchers in the field. This session will include new single cell imaging and quantitation strategies, live cell imaging, novel staining methods, i.e., biosensors, imaging modalities, quantitation algorithms, complex multi-parametric staining and detection followed by unsupervised clustering of data for analysis and the development and application of new imaging platforms, as well as other novel technologies relevant to HCS/HCA.

10 Sep - 12 Sep 2013

boston
United States of America
meeting website